Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
China
· Delayed Price · Currency is CNY 27.62
+0.01 (0.04%)
At close: Apr 14, 2025, 2:57 PM CST
SHA:688161 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,452 | 1,282 | 2,057 | 2,152 | 1,822 | Upgrade
|
| Other Revenue | - | 1.33 | 0.93 | 1.58 | 1.47 | Upgrade
|
| Revenue | 1,452 | 1,284 | 2,058 | 2,154 | 1,824 | Upgrade
|
| Revenue Growth (YoY) | 13.14% | -37.63% | -4.44% | 18.08% | 15.87% | Upgrade
|
| Cost of Revenue | - | 460.3 | 489.5 | 409.09 | 338.96 | Upgrade
|
| Gross Profit | 1,452 | 823.24 | 1,568 | 1,744 | 1,485 | Upgrade
|
| Selling, General & Admin | - | 621.81 | 786.46 | 827.36 | 710.75 | Upgrade
|
| Research & Development | - | 130.2 | 117.66 | 121.23 | 82.46 | Upgrade
|
| Other Operating Expenses | 1,180 | 14.21 | 28.89 | 31.26 | 40.25 | Upgrade
|
| Operating Expenses | 1,180 | 760.93 | 948.03 | 983.99 | 837.56 | Upgrade
|
| Operating Income | 271.74 | 62.31 | 620.45 | 760.46 | 647.25 | Upgrade
|
| Interest Expense | - | -0.95 | -0.61 | -0.61 | - | Upgrade
|
| Interest & Investment Income | - | 56.11 | 64.57 | 42.93 | 15.41 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -1.24 | 2.18 | -0.51 | -2.44 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.76 | 10.71 | 6.02 | -6.28 | -0.35 | Upgrade
|
| EBT Excluding Unusual Items | 270.98 | 126.94 | 692.6 | 795.99 | 659.88 | Upgrade
|
| Impairment of Goodwill | - | -0.17 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.02 | 0.23 | -0.11 | -0.45 | Upgrade
|
| Asset Writedown | - | - | - | - | -1.6 | Upgrade
|
| Other Unusual Items | - | 4.86 | 13.38 | 14.05 | 8.2 | Upgrade
|
| Pretax Income | 270.98 | 131.62 | 706.21 | 809.93 | 666.03 | Upgrade
|
| Income Tax Expense | 49.17 | 18.53 | 105.85 | 118.59 | 104.31 | Upgrade
|
| Earnings From Continuing Operations | 221.81 | 113.09 | 600.36 | 691.33 | 561.72 | Upgrade
|
| Minority Interest in Earnings | - | -0.78 | 0.35 | -1.01 | -3.32 | Upgrade
|
| Net Income | 221.81 | 112.32 | 600.7 | 690.32 | 558.4 | Upgrade
|
| Net Income to Common | 221.81 | 112.32 | 600.7 | 690.32 | 558.4 | Upgrade
|
| Net Income Growth | 97.49% | -81.30% | -12.98% | 23.62% | 26.43% | Upgrade
|
| Shares Outstanding (Basic) | 403 | 401 | 400 | 379 | 358 | Upgrade
|
| Shares Outstanding (Diluted) | 403 | 401 | 400 | 379 | 358 | Upgrade
|
| Shares Change (YoY) | 0.54% | 0.16% | 5.58% | 5.96% | 7.79% | Upgrade
|
| EPS (Basic) | 0.55 | 0.28 | 1.50 | 1.82 | 1.56 | Upgrade
|
| EPS (Diluted) | 0.55 | 0.28 | 1.50 | 1.82 | 1.56 | Upgrade
|
| EPS Growth | 96.43% | -81.33% | -17.58% | 16.67% | 17.29% | Upgrade
|
| Free Cash Flow | - | 76.46 | 392.8 | 675.84 | 594.54 | Upgrade
|
| Free Cash Flow Per Share | - | 0.19 | 0.98 | 1.78 | 1.66 | Upgrade
|
| Dividend Per Share | - | 0.120 | 0.410 | 0.520 | - | Upgrade
|
| Dividend Growth | - | -70.62% | -21.15% | - | - | Upgrade
|
| Gross Margin | 100.00% | 64.14% | 76.22% | 81.00% | 81.41% | Upgrade
|
| Operating Margin | 18.71% | 4.86% | 30.15% | 35.31% | 35.49% | Upgrade
|
| Profit Margin | 15.27% | 8.75% | 29.19% | 32.05% | 30.62% | Upgrade
|
| Free Cash Flow Margin | - | 5.96% | 19.09% | 31.38% | 32.60% | Upgrade
|
| EBITDA | 328.11 | 118.68 | 677.35 | 811.94 | 688.9 | Upgrade
|
| EBITDA Margin | 22.59% | 9.25% | 32.91% | 37.70% | 37.77% | Upgrade
|
| D&A For EBITDA | 56.37 | 56.37 | 56.91 | 51.48 | 41.65 | Upgrade
|
| EBIT | 271.74 | 62.31 | 620.45 | 760.46 | 647.25 | Upgrade
|
| EBIT Margin | 18.71% | 4.86% | 30.15% | 35.31% | 35.49% | Upgrade
|
| Effective Tax Rate | 18.14% | 14.08% | 14.99% | 14.64% | 15.66% | Upgrade
|
| Revenue as Reported | - | 1,284 | 2,058 | 2,154 | 1,824 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.